Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.
about
Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Prognostic value of 18F-cholin ...... h abiraterone or enzalutamide.
@en
Prognostic value of 18F-cholin ...... h abiraterone or enzalutamide.
@nl
type
label
Prognostic value of 18F-cholin ...... h abiraterone or enzalutamide.
@en
Prognostic value of 18F-cholin ...... h abiraterone or enzalutamide.
@nl
prefLabel
Prognostic value of 18F-cholin ...... h abiraterone or enzalutamide.
@en
Prognostic value of 18F-cholin ...... h abiraterone or enzalutamide.
@nl
P2093
P2860
P1476
Prognostic value of 18F-cholin ...... th abiraterone or enzalutamide
@en
P2093
Andrea Moretti
Emanuela Bianchi
Emanuela Scarpi
Federica Matteucci
Giovanni Paganelli
Lorena Rossi
Lorenzo Fantini
Monica Celli
Paola Caroli
Riccardo Galassi
P2860
P2888
P304
P356
10.1007/S00259-017-3866-2
P577
2017-11-06T00:00:00Z